Combodart

£24.99

Combodart Capsules treat symptoms of benign prostatic hyperplasia (BPH) in adult men. They improve urine flow and reduce the risk of urinary retention or surgery.
Packaging and branding may differ from image shown.

Clear Start Assessment

Combodart Capsules are a dual-action prescription treatment designed to relieve lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), a common condition in older men. It helps manage problems such as urinary urgency, frequent nighttime urination (nocturia), weak stream, and the sensation of incomplete bladder emptying.

How It Works

Combodart contains two active ingredients: dutasteride and tamsulosin. Dutasteride shrinks the enlarged prostate over time by reducing the levels of a hormone (DHT) that causes prostate growth. Tamsulosin relaxes the muscles in the prostate and bladder neck, improving urine flow and reducing pressure on the urinary tract. Together, they address both the static and dynamic components of urinary obstruction.

Why Choose Combodart Capsules

Combodart offers a comprehensive solution for men with urinary symptoms that impact daily activities and sleep. Its once-daily dosing improves convenience and adherence, while the combination therapy has been shown to significantly reduce the need for surgical intervention. Patients using Combodart often report fewer bathroom visits, improved flow, and reduced discomfort due to residual urine or straining.

Important Note

Combodart is for adult men only. It should not be handled by women who are pregnant or may become pregnant, as absorption of dutasteride can be harmful to a developing male fetus. The medication may affect semen quality and PSA test readings. If symptoms persist or worsen, medical reassessment may be necessary. Dizziness may occur, especially when standing up suddenly—caution is advised during activities requiring alertness.

Directions

Please refer to the medication’s patient information leaflet before starting any new medication.

  • Take one capsule daily, approximately 30 minutes after the same meal each day

  • Swallow the capsule whole—do not crush or chew

  • Consistent timing improves effectiveness
    Storage instructions:

  • Store below 25°C

  • Keep in original packaging

  • Keep out of reach of children

Ingredients

Active Ingredients:

  • Dutasteride 0.5mg

  • Tamsulosin hydrochloride 0.4mg

Other Ingredients:

  • Glycerol

  • Gelatin

  • Titanium dioxide

  • Iron oxide yellow

  • Lecithin (soya)

  • Medium chain triglycerides

Side Effects

Common side effects may include:

  • Reduced libido

  • Ejaculation disorders

  • Dizziness

Serious (rare) side effects:

  • Breast tenderness or lumps

  • Allergic skin reactions

  • Swelling of the face or throat

Stop the medicine and seek medical attention if serious side effects occur.

Warnings

Do not take Combodart if allergic to dutasteride, tamsulosin, or soya lecithin. This medicine is not suitable for women or children. Use with caution in men with liver disease. Avoid blood donation during treatment and for six months after the last dose. Combodart may affect PSA test results—inform your doctor before any prostate screening.

  • Combodart may interact with medications for blood pressure, antifungals, and antibiotics. Always inform your doctor about all medications you are taking before starting Combodart.
  • Combodart combines two active ingredients—dutasteride and tamsulosin—that work together to shrink the enlarged prostate and relax the muscles in the prostate and bladder neck, improving urine flow and reducing symptoms.
  • Combodart should be taken once daily, about 30 minutes after the same meal each day. The capsule must be swallowed whole and not chewed or opened.
  • Combodart is intended for use in adult men only. It is not suitable for women, children, or individuals with severe liver impairment. A doctor’s assessment is essential before use.
  • Combodart Capsules are used to treat moderate to severe symptoms of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland in men.